User profiles for Claudia M. Denkinger

Claudia M. Denkinger

Heidelberg University
Verified email at uni-heidelberg.de
Cited by 14624

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

CM Denkinger, M Janssen, U Schäkel, J Gall, A Leo… - Nature Cancer, 2023 - nature.com
Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with
high morbidity and mortality. Furthermore, impaired humoral response renders severe acute …

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis

CM Denkinger, SG Schumacher… - European …, 2014 - Eur Respiratory Soc
Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is endorsed for the detection of pulmonary
tuberculosis (TB). We performed a systematic review and meta-analysis to assess the …

Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis

…, S Ongarello, JA Sacks, CM Denkinger - PLoS …, 2021 - journals.plos.org
Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being
integrated in testing strategies around the world. Studies of the Ag-RDTs have shown …

Gamma interferon release assays for detection of Mycobacterium tuberculosis infection

M Pai, CM Denkinger, SV Kik… - Clinical microbiology …, 2014 - Am Soc Microbiol
Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI. …

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

…, CC Boehme, JJ Ellner, CM Denkinger… - The Lancet infectious …, 2018 - thelancet.com
Background The Xpert MTB/RIF assay is an automated molecular test that has improved the
detection of tuberculosis and rifampicin resistance, but its sensitivity is inadequate in …

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

…, CM Denkinger, D Persing, R Kwiatkowski, M Jones… - MBio, 2017 - Am Soc Microbiol
The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance
(RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-…

Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis

…, A Benedetti, NR Pollock, CM Denkinger - Journal of clinical …, 2021 - Am Soc Microbiol
Nasopharyngeal (NP) swabs are considered the highest-yield sample for diagnostic testing
for respiratory viruses, including SARS-CoV-2. The need to increase capacity for SARS-CoV-…

Defining the needs for next generation assays for tuberculosis

CM Denkinger, SV Kik, DM Cirillo… - The Journal of …, 2015 - academic.oup.com
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed
urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics …

In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of …

CM Denkinger, M Denkinger, JJ Kort… - The Journal of …, 2003 - journals.aai.org
Macrophage migration inhibitory factor (MIF) is a cytokine that plays a critical role in the
regulation of macrophage effector functions and T cell activation. However, its role in the …

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

…, C Gilpin, S Niemann, CM Denkinger… - European …, 2017 - Eur Respiratory Soc
A clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis
is required to accelerate the development of rapid drug susceptibility testing methods …